Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sigilon

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Mar 25, 2021 5:38pm

152 Views

Post# 32883108

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Sigilon

In the context that I'm thinking the market would not have the opportunity to perceive it as bad. It all depends on whos behind it. Anyways like I said they are not going to do a RS and very likely will have more than ample opportunity to do it naturally.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments